Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A cross-reaction between beta2-microglobulin and kappa-light chains

A B Gottlieb, M Engelhard, H G Kunkel

    Journal of Immunology (Baltimore, Md. : 1950)
    |December 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Health-related quality of life in patients with generalized pustular psoriasis: A systematic literature review.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2023
    Same author

    Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy study.

    The British journal of dermatology·2021
    Same author

    Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2).

    The British journal of dermatology·2020
    Same author

    Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies.

    The British journal of dermatology·2020
    Same author

    Older adults on systemic treatment for psoriasis and risk of infection: a propensity score-matched population-based study.

    The British journal of dermatology·2020
    Same author

    Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial.

    The British journal of dermatology·2019

    Certain antisera targeting immunoglobulins with kappa-chains cross-react with beta2-microglobulin. These antibodies affect T cells, suggesting a role in previous immunoglobulin studies.

    Area of Science:

    • Immunology
    • Cell Biology

    Background:

    • Antisera to immunoglobulins can exhibit cross-reactivity.
    • Kappa-light chains are a component of certain immunoglobulins.

    Purpose of the Study:

    • To investigate cross-reactivity between immunoglobulin antisera and beta2-microglobulin.
    • To determine the cellular effects of these cross-reactive antibodies.

    Main Methods:

    • Production of antisera to purified immunoglobulin fragments.
    • Cellular assays including fluorescence and cytotoxicity.
    • Absorption studies using purified kappa-chains, lambda-chains, and beta2-microglobulin.

    Main Results:

    • An antiserum to gamma-globulin fragments showed cross-reactivity with beta2-microglobulin.

    Related Experiment Videos

  • Cross-reactive antibodies induced positive reactions in T cells.
  • Reactivity was absorbed by kappa-chains and beta2-microglobulin, but not lambda-chains.

    • Conclusions:

    • Immunoglobulin antisera can contain antibodies that cross-react with beta2-microglobulin.
    • This cross-reactivity impacts T cell analysis.
    • Potential implications for interpreting prior studies on immunoglobulin effects on T cells.